Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.

Lin, Wen; Li, Yinke; Shi, Qiongzhi; Liao, Xiangru; Zeng, Yuan; Tian, Wei; Xie, Xiangyang; Liu, Hui

Lin, Wen; Li, Yinke; Shi, Qiongzhi; Liao, Xiangru; Zeng, Yuan; Tian, Wei; Xie, Xiangyang; Liu, Hui.

Afiliación

Lin W; Department of Clinical Laboratory, Huangshi Love & Health Hospital of Hubei Province, Huangshi, Hubei, China.
Li Y; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Shi Q; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Liao X; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Zeng Y; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Tian W; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Xie X; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.
Liu H; Department of Pharmacy, General Hospital of Central Theater of the PLA, Wuhan, Hubei, China.

PLoS One ; 17(2): e0264457, 2022.

Article en En | MEDLINE | ID: mdl-35213658

Asunto(s)

Topiramato; Animales; Disponibilidad Biológica; Preparaciones de Acción Retardada/farmacocinética; Preparaciones de Acción Retardada/farmacología; Perros; Evaluación Preclínica de Medicamentos; Femenino; Masculino; Comprimidos; Topiramato/farmacocinética; Topiramato/farmacología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Topiramato Idioma: En Revista: PLoS One Año: 2022 Tipo del documento: Article País de afiliación: China